eczema

A Pfizer Drug Moves Closer to Approval in Another Important Indication
Motley Fool
Wed, 11/3/21 - 10:38 am
Cibingo
Pfizer
Europe
eczema
atopic dermatitis
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
atopic dermatitis
eczema
nocturnal scratch
digital endpoint
AbbVie
Janssen
JNJ
Novartis
Pfizer
UCB Pharma
digital pharma
Amgen reveals midphase eczema data behind its $400M bet
Fierce Biotech
Mon, 10/4/21 - 10:38 am
Amgen
Kyowa Kirin
clinical trials
eczema
antibodies
Key drug in Sanofi’s $1.45bn Kymab buyout shows promise in eczema
Pharmaforum
Fri, 10/1/21 - 10:48 am
Sanofi
eczema
M&A
Kymab
KY1005
clinical trials
Pfizer gets first approval, in UK, for Xeljanz follow-up Cibinqo
Pharmaforum
Thu, 09/9/21 - 11:13 pm
Pfizer
Cibinqo
atopic dermatitis
eczema
UK
Xeljanz
Cara's stock tanks as atopic dermatitis phase 2 misses endpoint
Fierce Biotech
Fri, 04/30/21 - 10:45 am
Cara Therapeutics
atopic dermatitis
eczema
clinical trials
Korsuva
FDA hits Leo Pharma with a CRL for what the biotech says are questions about the 'device component' of eczema candidate
Endpoints
Fri, 04/30/21 - 10:43 am
LEO Pharma
FDA
atopic dermatitis
eczema
monoclonal antibodies
Dupixent
FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class
Endpoints
Wed, 04/7/21 - 10:30 am
FDA
JAK inhibitors
Eli Lilly
olumiant
Pfizer
abrocitinib
eczema
Incyte Says FDA Grants Priority Review For Eczema Cream
Yahoo/SmarterAnalyst
Mon, 02/22/21 - 11:00 am
Incyte
eczema
FDA
priority review
ruxolitinib
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Mon, 02/8/21 - 10:25 am
Dupixent
Regeneron
Sanofi
eczema
Sanofi inks $1.1B Kymab buyout to bag midphase eczema drug
Fierce Biotech
Mon, 01/11/21 - 09:57 am
Sanofi
Kymab
M&A
atopic dermatitis
eczema
monoclonal antibodies
Novartis dumps Ziarco eczema drug, taking $485M hit
Fierce Biotech
Tue, 07/21/20 - 10:51 am
Novartis
eczema
Ziarco
M&A
ZPL389
LEO eyeing 2021 US launch for eczema drug tralokinumab
Pharmaforum
Fri, 07/10/20 - 10:47 am
LEO Pharma
eczema
tralokinumab
Sanofi
Dupixent
AAD 2020 – Leo’s eczema wildcard proves tame
EP Vantage
Fri, 06/12/20 - 08:02 pm
LEO Pharma
Sanofi
Regeneron
eczema
atopic dermatitis
AAD
tralokinumab
Pfizer's JAK abrocitinib comes through in teen eczema test
Fierce Biotech
Wed, 06/10/20 - 10:43 am
Pfizer
abrocitinib
eczema
atopic dermatitis
clinical trials
New safety data expose potential weakness as Pfizer's abrocitinib takes on Dupixent in eczema
Endpoints
Thu, 06/4/20 - 11:15 am
Pfizer
abrocitinib
Dupixent
clinical trials
eczema
LEO Pharma mounts another challenge to the eczema giants, betting $40M cash on a drug from China
Endpoints
Wed, 04/15/20 - 10:42 am
LEO Pharma
eczema
asthma
clinical trials
FB825
China
Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema
Motley Fool
Thu, 02/13/20 - 12:12 am
Eli Lilly
Incyte
olumiant
eczema
clinical trials
atopic dermatitis
Pfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema Drug
TheStreet.com
Fri, 09/27/19 - 09:29 am
Pfizer
clinical trials
eczema
abrocitinib
Dermira shares double on positive eczema data
Biopharma Dive
Mon, 03/18/19 - 05:03 pm
Dermira
lebrikizumab
clinical trials
eczema

Pages